Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Other Non-Current Liabilities: 2018

Historic Other Non-Current Liabilities for Cidara Therapeutics (CDTX) over the last 1 years, with Dec 2018 value amounting to $411,000.

  • Cidara Therapeutics' Other Non-Current Liabilities was N/A to $700,000 in Q1 2019 from the same period last year, while for Mar 2019 it was $700,000, marking a year-over-year change of. This contributed to the annual value of $411,000 for FY2018, which is N/A change from last year.
  • Per Cidara Therapeutics' latest filing, its Other Non-Current Liabilities stood at $411,000 for FY2018.
  • In the past 5 years, Cidara Therapeutics' Other Non-Current Liabilities ranged from a high of $411,000 in FY2018 and a low of $411,000 during FY2018.
  • Its 1-year average for Other Non-Current Liabilities is $411,000, with a median of $411,000 in 2018.